TUESDAY, SEPTEMBER 15, 2026KO
Finance & Markets|Jan 14, 2026|4 MIN READ

[R&E] Era of Structural Growth Led by AI and Defense; Shipbuilding Stocks Accelerate Valuation Re-rating through U.S. Naval Vessel Cooperation

[R&E] Era of Structural Growth Led by AI and Defense; Shipbuilding Stocks Accelerate Valuation Re-rating through U.S. Naval Vessel Cooperation

[R&E: Research & Epoch]
This is News Epoch's signature report that analyzes vast market data to overview a new era of investment.

Market Overview: Key Indicators and Trends

Overnight, U.S. stock markets closed lower as expectations for early interest rate cuts weakened and oil prices surged following Trump's remarks. Financial stocks, particularly JPMorgan (-4.2%), led the decline as they faced policy uncertainty. However, the domestic stock market showed a distinct differentiated trend centered on large-cap stocks. In particular, Samsung Biologics renewed its 52-week high (1,908,000 won), driving investor sentiment in the bio sector, while supply and demand are increasingly concentrating on sectors with clear growth stories, such as semiconductor back-end processes, defense, and shipbuilding. The market's temperature is heating up amid expectations of structural growth in specific industries rather than the overall index.

Key Industry Issues and Insights

As the global technology paradigm is reorganized around AI, the domestic semiconductor and ICT components sectors have entered a structural upcycle. The increase in the number of layers and the larger area of FC-BGA (Flip-Chip Ball Grid Array) for AI are continuously causing yield drops, deepening the excess demand environment in the mid-to-long term. In this environment, Samsung Electro-Mechanics, the only domestic FC-BGA supplier, saw its target price revised upward by 12.9% to 350,000 won, boosted by the acquisition of new AI customers. Back-end component companies Hana Materials and Wonik QnC are also expected to see steep profit growth in 2026, emerging as core choices in the semiconductor scale-up phase.

Furthermore, the pharmaceutical/bio sector has joined as a powerful growth axis. With the opening of the 'J.P. Morgan Healthcare Conference', the world's largest bio event, Samsung Biologics recorded a steep upward trend as expectations for large-scale orders and business vision announcements were pre-reflected. This is acting as a mechanism for the valuation re-evaluation of the overall bio sector, which had been alienated until now.

Increasing geopolitical risks and energy security trends are driving strong growth in the infrastructure and defense sectors. Hanwha Systems, whose space business value has been highlighted, saw its stock price surge 63.1% compared to the beginning of the year, proving the explosive power of the defense theme. Shipbuilding stocks such as HD Hyundai Heavy Industries and Hanwha Ocean are aiming for multiple expansions through the new momentum of entering the U.S. naval vessel market. In addition, LS ELECTRIC is projected to achieve at least 1 trillion won in new orders in the fourth quarter alone, supported by favorable demand for power equipment in North America.

Market Signals

  • New High for Bio Bellwether: Samsung Biologics renewed its 52-week high during intraday trading on expectations of the JPM Conference, signaling the bio sector's return as a market leader.

  • Excess Demand for AI Advanced Packaging: The target price of Samsung Electro-Mechanics, the only domestic FC-BGA supplier, was revised upward by 12.9% to 350,000 won, reflecting expectations for surging demand for AI semiconductors.

  • Geopolitical Risks and Defense: Driven by increasing geopolitical risks, such as Trump's remarks, and the highlighting of space business value, Hanwha Systems' stock price has surged 63.1% since the beginning of the year.

  • Strength in Short-Term Credit Bonds: Amid the emergence of the January effect, strength in short-term corporate bonds and specialized credit finance bonds is projected compared to ultra-high-grade bonds in the domestic credit bond market.

Epoch View: Investment Implications

The current market is securing dominance centered on sectors that have obtained earnings visibility for 2026 and beyond. The core investment strategy is to bet on long cycles of structural growth rather than short-term issues. The semiconductor packaging sector (Samsung Electro-Mechanics), the core of AI infrastructure, and the healthcare sector led by the bio bellwether (Samsung Biologics) possess clear momentum, requiring a continuous expansion in portfolio weighting.

Simultaneously, the three major shipbuilders and power equipment companies (LS ELECTRIC), which benefit from geopolitical risks and the reorganization of the global supply chain, will provide mid-to-long-term multiple expansion opportunities. On the other hand, the cosmetics and retail sectors, whose earnings momentum has weakened due to sluggish Chinese consumption, require a cautious wait-and-see approach until uncertainties are resolved.

This content was generated by News Epoch's proprietary AI algorithm, which tracks and analyzes public data from research centers of major domestic securities firms in real time.
It is an objective summary based on collected data, and it is clarified that this is not an investment solicitation or recommendation for specific stocks.

Jisoo Yeom Reporter
Copyright holder News Epoch, ushering in a new era of journalism powered by data. Unauthorized reproduction, redistribution, and AI training use are prohibited.

Company financial data, investment reports, and startup analysis — all in one place

Explore Pitchdeck

Curated news, every week — straight to your inbox

Every Friday · Unsubscribe anytime

#Business#Research